# CRBU (Caribou Biosciences, Inc.) - SEC EDGAR Financial Statements

> Caribou Biosciences, Inc. reported $9.44M in revenue and a net loss of $102.5M for the trailing twelve months ended September 30, 2026 (down 26.9% year over year), with a -1140.6% operating margin.

- Canonical: https://convexityos.com/fundamentals/CRBU
- Markdown: https://convexityos.com/fundamentals/CRBU.md
- SEC CIK: 0001619856
- Reporting currency: USD
- Latest filing period: September 30, 2026
- Last synced: Nov 20, 2026, 05:53 UTC
- Primary source: [SEC EDGAR](https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001619856&type=&dateb=&owner=include&count=40)

## Key Financial Metrics

| Metric | Period | Value | Notes |
| --- | --- | --- | --- |
| Revenue | TTM | $9.44M | -26.9% YoY |
| Operating Income | TTM | -$107.7M | -1140.6% margin |
| Net Income | TTM | -$102.5M | -1085.0% net margin |
| Diluted EPS | TTM | -$0.95 | Split-adjusted |
| Free Cash Flow | TTM | -$92.99M | -984.6% FCF margin |
| Cash & ST Investments | Sep 30, 2026 | $94.80M | Total debt: $26.34M |

## Income Statement

### Income Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $11.16M | $9.99M | $34.48M | $13.85M | $9.60M | $12.36M | $5.79M |
| Research & Development | $109.4M | $130.2M | $112.1M | $82.23M | $52.26M | $34.42M | $23.64M |
| Total Operating Expenses | $159.5M | $176.6M | $150.5M | $120.2M | $76.58M | $48.48M | $40.09M |
| **Operating Income** | -$148.3M | -$166.6M | -$116.1M | -$106.4M | -$66.98M | -$36.12M | -$34.30M |
| **EBITDA** | -$144.7M | -$162.7M | -$112.5M | -$104.8M | -$66.00M | -$35.22M | -$33.55M |
| Interest Income | -- | -- | -- | -- | $148K | $236K | $1.05M |
| Interest Expense | -- | -- | -- | -- | $8.0K | $20K | $4.0K |
| Income Before Tax | -$148.7M | -$149.1M | -$101.9M | -$99.35M | -$66.60M | -$36.13M | -$30.97M |
| Income Tax Expense | -$550K | -$9.0K | $193K | $70K | $321K | -$1.82M | -$7.54M |
| **Net Income** | -$148.1M | -$149.1M | -$102.1M | -$99.42M | -$66.92M | -$34.31M | -$23.43M |
| Basic EPS | -$1.59 | -$1.65 | -$1.38 | -$1.64 | -$2.11 | -$4.01 | -$2.80 |
| **Diluted EPS** | -$1.59 | -$1.65 | -$1.38 | -$1.64 | -$2.11 | -$4.01 | -$2.80 |
| Basic Shares Outstanding | 93.4M | 90.3M | 73.8M | 60.8M | 31.7M | 8.5M | 8.4M |
| Diluted Shares Outstanding | 93.4M | 90.3M | 73.8M | 60.8M | 31.7M | 8.5M | 8.4M |

### Income Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Revenue** | $1.61M | $1.50M | $2.40M | $3.94M | $2.20M | $2.67M | $2.35M | $2.08M |
| Research & Development | $21.35M | $18.94M | $20.61M | $23.82M | $22.40M | $27.69M | $35.53M | $30.46M |
| Total Operating Expenses | $29.25M | $26.84M | $28.68M | $32.39M | $31.60M | $50.24M | $45.27M | $40.95M |
| **Operating Income** | -$27.64M | -$25.34M | -$26.28M | -$28.45M | -$29.40M | -$47.58M | -$42.91M | -$38.88M |
| **EBITDA** | -$27.05M | -$24.71M | -$25.63M | -$27.77M | -$28.77M | -$46.41M | -$41.75M | -$37.69M |
| Income Tax Expense | -- | -- | $0 | -$550K | $0 | -- | $0 | -$9.0K |
| **Net Income** | -$26.61M | -$24.28M | -$25.09M | -$26.49M | -$27.55M | -$54.10M | -$39.99M | -$35.49M |
| Basic EPS | -$0.25 | -$0.24 | -$0.26 | -- | -$0.30 | -$0.58 | -$0.43 | -- |
| **Diluted EPS** | -$0.25 | -$0.24 | -$0.26 | -- | -$0.30 | -$0.58 | -$0.43 | -- |
| Basic Shares Outstanding | 107.5M | 101.0M | 95.9M | -- | 93.3M | 93.0M | 92.7M | -- |
| Diluted Shares Outstanding | 107.5M | 101.0M | 95.9M | -- | 93.3M | 93.0M | 92.7M | -- |

## Balance Sheet

### Balance Sheet (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
| --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $12.36M | $16.29M | $51.16M | $58.34M | $240.4M | $15.95M |
| Short-Term Investments | $127.0M | $193.2M | $277.7M | $189.3M | $135.4M | $0 |
| **Cash & Short-Term Investments** | $142.8M | $249.4M | $372.4M | $317.0M | $413.5M | $15.95M |
| Accounts Receivable, Net | $69K | $265K | $148K | $202K | $1.15M | $150K |
| **Total Current Assets** | $145.2M | $219.4M | $338.8M | $260.2M | $391.2M | $24.31M |
| Property, Plant & Equipment, Net | $6.76M | $19.28M | $18.27M | $10.68M | $4.89M | $3.50M |
| Long-Term Investments | $3.50M | $39.85M | $43.58M | $69.37M | $37.68M | $0 |
| Other Non-Current Assets | $2.20M | $5.52M | $1.59M | $1.54M | $975K | $612K |
| **Total Non-Current Assets** | $30.14M | $93.94M | $93.37M | $113.5M | $51.16M | $11.74M |
| **Total Assets** | $175.4M | $313.3M | $432.2M | $373.8M | $442.4M | $36.05M |
| Accounts Payable | $5.78M | $2.48M | $3.12M | $1.15M | $3.99M | $2.60M |
| Deferred Revenue (Current) | $1.90M | $3.13M | $2.85M | $9.94M | $8.70M | $50K |
| Other Current Liabilities | $2.68M | $1.68M | $1.11M | $1.37M | $788K | $629K |
| **Total Current Liabilities** | $25.41M | $30.65M | $28.30M | $28.13M | $25.83M | $12.39M |
| Deferred Revenue (Non-Current) | $1.75M | $3.32M | $6.10M | $15.95M | $22.03M | $937K |
| **Total Non-Current Liabilities** | $27.78M | $29.71M | $35.51M | $44.77M | $28.70M | $5.77M |
| **Total Liabilities** | $53.19M | $60.36M | $63.81M | $72.89M | $54.53M | $18.16M |
| **Total Debt (incl. Leases)** | $27.23M | $26.49M | $27.11M | $27.75M | -- | -- |
| Common Stock | $9.0K | $9.0K | $8.0K | $6.0K | $6.0K | $1.0K |
| Retained Earnings | -$596.5M | -$448.4M | -$299.3M | -$197.2M | -$97.79M | -$30.87M |
| Accumulated Other Comp. Income | $103K | $255K | $30K | -$1.52M | -$135K | $0 |
| **Total Stockholders' Equity** | $122.2M | $253.0M | $368.4M | $300.9M | $387.8M | -$23.44M |
| Total Equity | $122.2M | $253.0M | $368.4M | $300.9M | $387.8M | -$23.44M |

### Balance Sheet (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash & Cash Equivalents | $26.06M | $26.19M | $12.06M | $12.36M | $11.14M | $25.20M | $29.42M | $16.29M |
| Short-Term Investments | $68.74M | $86.12M | $105.6M | $127.0M | $136.1M | $158.7M | $179.0M | $193.2M |
| **Cash & Short-Term Investments** | $94.80M | $113.8M | $118.6M | $142.8M | $159.2M | $183.9M | $212.5M | $249.4M |
| Accounts Receivable, Net | $518K | $203K | $227K | $69K | $242K | $71K | $88K | $265K |
| **Total Current Assets** | $100.1M | $116.6M | $122.4M | $145.2M | $155.5M | $192.5M | $217.3M | $219.4M |
| Property, Plant & Equipment, Net | $4.87M | $5.50M | $6.12M | $6.76M | $7.60M | $8.18M | $18.52M | $19.28M |
| Long-Term Investments | $0 | $1.50M | $1.00M | $3.50M | $11.95M | $0 | $3.99M | $39.85M |
| Other Non-Current Assets | $1.38M | $2.14M | $2.14M | $2.20M | $3.78M | $3.62M | $5.04M | $5.52M |
| **Total Non-Current Assets** | $22.95M | $26.18M | $26.62M | $30.14M | $39.48M | $28.40M | $56.33M | $93.94M |
| **Total Assets** | $123.0M | $142.8M | $149.0M | $175.4M | $195.0M | $220.9M | $273.7M | $313.3M |
| Accounts Payable | $5.05M | $3.08M | $3.50M | $5.78M | $3.80M | $3.24M | $3.87M | $2.48M |
| Deferred Revenue (Current) | $370K | $372K | $994K | $1.90M | $2.22M | $2.83M | $2.83M | $3.13M |
| Other Current Liabilities | $2.03M | $1.70M | $732K | $2.68M | $1.86M | $2.07M | $1.54M | $1.68M |
| **Total Current Liabilities** | $20.14M | $17.97M | $19.67M | $25.41M | $28.06M | $28.89M | $28.49M | $30.65M |
| Deferred Revenue (Non-Current) | $1.37M | $1.42M | $1.65M | $1.75M | $1.76M | $1.77M | $2.62M | $3.32M |
| **Total Non-Current Liabilities** | $26.25M | $26.70M | $27.31M | $27.78M | $25.08M | $25.88M | $27.94M | $29.71M |
| **Total Liabilities** | $46.39M | $44.67M | $46.98M | $53.19M | $53.14M | $54.77M | $56.43M | $60.36M |
| **Total Debt (incl. Leases)** | $26.34M | $26.66M | $26.95M | $27.23M | $25.46M | $25.85M | $26.22M | $26.49M |
| Common Stock | $11K | $11K | $10K | $9.0K | $9.0K | $9.0K | $9.0K | $9.0K |
| Retained Earnings | -$672.5M | -$645.9M | -$621.6M | -$596.5M | -$570.0M | -$542.5M | -$488.4M | -$448.4M |
| Accumulated Other Comp. Income | -$80K | -$71K | -$23K | $103K | $93K | $40K | $167K | $255K |
| **Total Stockholders' Equity** | $76.63M | $98.10M | $102.0M | $122.2M | $141.8M | $166.1M | $217.2M | $253.0M |
| Total Equity | $76.63M | $98.10M | $102.0M | $122.2M | $141.8M | $166.1M | $217.2M | $253.0M |

## Cash Flow Statement

### Cash Flow Statement (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$148.1M | -$149.1M | -$102.1M | -$99.42M | -$66.92M | -$34.31M | -$23.43M |
| Depreciation & Amortization | $3.65M | $3.93M | $3.52M | $1.62M | $984K | $900K | $751K |
| Stock-Based Compensation | $12.68M | $16.71M | $13.75M | $11.72M | $3.45M | $1.00M | $1.23M |
| Change in Receivables | $196K | -$117K | $54K | $951K | -$1.00M | -$146K | $617K |
| Change in Payables | $3.25M | -$354K | $1.82M | -$2.72M | $1.14M | $43K | $1.18M |
| **Operating Cash Flow** | -$111.0M | -$138.2M | -$93.29M | -$90.97M | -$32.52M | -$33.22M | -$32.01M |
| Capital Expenditure | -$1.36M | -$4.88M | -$11.61M | -$6.45M | -$2.12M | -$317K | -$884K |
| **Free Cash Flow** | -$112.4M | -$143.1M | -$104.9M | -$97.42M | -$34.64M | -$33.53M | -$32.89M |
| Purchases of Investments | -$149.2M | -$304.4M | -$394.8M | -$339.1M | -$173.3M | $0 | $0 |
| **Investing Cash Flow** | $102.2M | $86.61M | -$68.18M | -$93.25M | -$176.4M | $6.36M | $27.23M |
| Common Stock Issued | $4.07M | $15.19M | $1.01M | $0 | -- | -- | -- |
| **Financing Cash Flow** | $4.82M | $16.72M | $154.3M | $2.13M | $433.4M | $1.74M | $172K |
| **Net Change in Cash** | -$3.93M | -$34.87M | -$7.18M | -$182.1M | $224.5M | -$25.12M | -$4.60M |

### Cash Flow Statement (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Net Income | -$26.61M | -$24.28M | -$25.09M | -$26.49M | -$27.55M | -$54.10M | -$39.99M | -$35.49M |
| Depreciation & Amortization | $590K | $625K | $649K | $682K | $631K | $1.17M | $1.17M | $1.18M |
| Stock-Based Compensation | $2.16M | $2.48M | $2.36M | $2.74M | $2.93M | $3.13M | $3.88M | $3.91M |
| Change in Receivables | -$315K | $24K | -$158K | $173K | -$171K | $17K | $177K | -$81K |
| Change in Payables | $1.97M | -$423K | -$2.22M | $1.92M | $561K | -$630K | $1.40M | -$229K |
| **Operating Cash Flow** | -$22.52M | -$22.79M | -$26.98M | -$20.82M | -$25.18M | -$28.26M | -$36.73M | -$35.47M |
| Capital Expenditure | -$19K | -$1.0K | -$72K | $216K | -$115K | -$418K | -$1.04M | -$518K |
| **Free Cash Flow** | -$22.54M | -$22.79M | -$27.06M | -$20.61M | -$25.30M | -$28.68M | -$37.77M | -$35.99M |
| Purchases of Investments | -$15.94M | -$20.50M | -$22.09M | -$44.03M | -$57.45M | -$32.22M | -$15.53M | -$55.50M |
| **Investing Cash Flow** | $19.39M | $18.94M | $23.98M | $17.97M | $10.85M | $24.04M | $49.38M | $15.93M |
| Common Stock Issued | $2.68M | $17.92M | $2.22M | $4.07M | $0 | $0 | $0 | $3.86M |
| **Financing Cash Flow** | $2.99M | $17.94M | $2.70M | $4.07M | $277K | $6.0K | $468K | $3.86M |
| **Net Change in Cash** | -$137K | $14.09M | -$303K | $1.22M | -$14.06M | -$4.22M | $13.12M | -$15.68M |

## Profitability Ratios & YoY Growth

### Profitability Ratios & YoY Growth (Annual)

| Line Item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1329.4% | -1667.2% | -336.6% | -768.2% | -697.8% | -292.2% | -592.7% |
| **Net Profit Margin** | -1327.4% | -1491.9% | -296.1% | -717.8% | -697.3% | -277.6% | -404.8% |
| Return on Equity (ROE) | -121.2% | -58.9% | -27.7% | -33.0% | -17.3% | -- | -- |
| Return on Assets (ROA) | -84.5% | -47.6% | -23.6% | -26.6% | -15.1% | -95.2% | -- |
| Current Ratio | 5.71x | 7.16x | 11.97x | 9.25x | 15.15x | 1.96x | -- |
| Quick Ratio | 5.62x | 8.15x | 13.16x | 11.28x | 16.05x | 1.30x | -- |
| Debt to Equity | 0.22x | 0.10x | 0.07x | 0.09x | -- | -- | -- |
| **Revenue Growth (YoY)** | +11.7% | -71.0% | +148.9% | +44.3% | -22.4% | +113.6% | -- |
| 5Y Revenue / Share Growth | -91.7% | -84.0% | -- | -- | -- | -- | -- |

### Profitability Ratios & YoY Growth (Quarterly)

| Line Item | Sep 2026 | Jun 2026 | Mar 2026 | Dec 2025 | Sep 2025 | Jun 2025 | Mar 2025 | Dec 2024 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- |
| **Operating Margin** | -1140.6% | -1090.9% | -1175.7% | -1329.4% | -1708.1% | -1837.6% | -1648.8% | -1667.2% |
| **Net Profit Margin** | -1085.0% | -1030.4% | -1189.1% | -1327.4% | -1690.4% | -1800.9% | -1490.8% | -1491.9% |
| Return on Equity (ROE) | -133.7% | -105.4% | -130.6% | -121.2% | -110.8% | -98.9% | -68.1% | -58.9% |
| Return on Assets (ROA) | -83.3% | -72.4% | -89.4% | -84.5% | -80.6% | -74.4% | -54.0% | -47.6% |
| Current Ratio | 4.97x | 6.49x | 6.22x | 5.71x | 5.54x | 6.66x | 7.63x | 7.16x |
| Quick Ratio | 4.73x | 6.34x | 6.04x | 5.62x | 5.68x | 6.37x | 7.46x | 8.15x |
| Debt to Equity | 0.34x | 0.27x | 0.26x | 0.22x | 0.18x | 0.16x | 0.12x | 0.10x |
| **Revenue Growth (YoY)** | -26.9% | -43.8% | +1.9% | +89.7% | +8.6% | -23.0% | -3.1% | -41.6% |

## Related Companies

[AMZN (Amazon.com, Inc.)](https://convexityos.com/fundamentals/AMZN), [WMT (Walmart Inc.)](https://convexityos.com/fundamentals/WMT), [AAPL (Apple Inc.)](https://convexityos.com/fundamentals/AAPL), [GOOG (Alphabet Inc.)](https://convexityos.com/fundamentals/GOOG), [UNH (UnitedHealth Group Incorporated)](https://convexityos.com/fundamentals/UNH), [CVS (CVS HEALTH Corp)](https://convexityos.com/fundamentals/CVS), [MCK (McKESSON CORPORATION)](https://convexityos.com/fundamentals/MCK), [BRK-A (Berkshire Hathaway Inc.)](https://convexityos.com/fundamentals/BRK-A)

---

## About Convexity

Published by [Convexity](https://convexityos.com/), a primary-source financial intelligence terminal built on SEC EDGAR filings, XBRL financial statements, options, macro data, and cited AI research. Free tier with no card and published prices at https://convexityos.com/pricing; Streamable HTTP MCP server at https://convexityos.com/mcp; full site index at https://convexityos.com/llms.txt.
